South Africa's AstraZeneca suspension underlines urgency of local vaccine manufacture
The Greens say the suspension of the AstraZeneca vaccine roll-out in South Africa shows the need for the government to establish a publicly-owned mRNA vaccine manufacturer in Australia.
Australia needs to be nimble and able to quickly adapt vaccines to ever-mutating strains of COVID, which would only be possible with a local, publicly owned facility that puts health, not profits, first.
Leader of the Australian Greens Adam Bandt MP said: